Dare Bioscience, Inc. Quarterly Debt-to-equity in % from Q1 2018 to Q4 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Dare Bioscience, Inc. quarterly Debt-to-equity history and growth rate from Q1 2018 to Q4 2024.
  • Dare Bioscience, Inc. Debt-to-equity for the quarter ending December 31, 2024 was -585 %, a 71.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 -585 +1.48K +71.7% Dec 31, 2024
Q3 2024 -611 -1.62K -161% Sep 30, 2024
Q2 2024 -630 -902 -331% Jun 30, 2024
Q1 2024 -492 -625 -469% Mar 31, 2024
Q4 2023 -2.07K -2.16K -2341% Dec 31, 2023
Q3 2023 1.01K +945 +1569% Sep 30, 2023
Q2 2023 272 +220 +418% Jun 30, 2023
Q1 2023 133 +78.9 +145% Mar 31, 2023
Q4 2022 92.2 +33 +55.7% Dec 31, 2022
Q3 2022 60.3 -35.5 -37.1% Sep 30, 2022
Q2 2022 52.5 -327 -86.2% Jun 30, 2022
Q1 2022 54.3 -3.17K -98.3% Mar 31, 2022
Q4 2021 59.2 -3.28K -98.2% Dec 31, 2021
Q3 2021 95.8 -1.12K -92.1% Sep 30, 2021
Q2 2021 379 -42.2 -10% Jun 30, 2021
Q1 2021 3.22K +3.05K +1763% Mar 31, 2021
Q4 2020 3.34K +3.23K +2873% Dec 31, 2020
Q3 2020 1.21K +1.18K +3104% Sep 30, 2020
Q2 2020 421 +398 +1751% Jun 30, 2020
Q1 2020 173 +158 +1060% Mar 31, 2020
Q4 2019 112 +102 +1036% Dec 31, 2019
Q3 2019 37.9 +29.5 +353% Sep 30, 2019
Q2 2019 22.8 +16.7 +274% Jun 30, 2019
Q1 2019 14.9 +6.7 +81.6% Mar 31, 2019
Q4 2018 9.9 Dec 31, 2018
Q3 2018 8.36 Sep 30, 2018
Q2 2018 6.09 Jun 30, 2018
Q1 2018 8.21 Mar 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.